Integra Lifesciences Holdings (IART) Other Non Operating Income (2009 - 2026)

Integra Lifesciences Holdings (IART) has 18 years of Other Non Operating Income data on file, last reported at $4.5 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 3211.11% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 48.46% YoY), and the FY2025 full-year result was -$2.4 million, down 159.61% from the prior year.
• Other Non Operating Income grew to $4.5 million in Q1 2026, from $581000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $4.5 million in Q1 2026 to a low of -$1.9 million in Q2 2025.
• A 5-year average of $1.3 million and a median of $1.4 million in 2023 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income sank 235.42% in 2025 and soared 3211.11% in 2026, its largest moves.
• Tracing IART's Other Non Operating Income over 5 years: stood at $4.0 million in 2022, then slumped by 49.05% to $2.0 million in 2023, then sank by 50.07% to $1.0 million in 2024, then tumbled by 42.19% to $581000.0 in 2025, then soared by 671.08% to $4.5 million in 2026.
• Business Quant data shows IART's Other Non Operating Income at $4.5 million in Q1 2026, $581000.0 in Q4 2025, and -$842000.0 in Q3 2025.